Shining a light on intestinal traffic

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Murphy, Carola T ^a   Nally, Kenneth ^a   Shanahan, Fergus ^a   Melgar, Silvia ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AJM 300; ALICAFORSEN; CCX 282B; CHEMOKINE; FINGOLIMOD; INTEGRIN; ISIS 2303; MDX 1100; MONOCLONAL ANTIBODY; NATALIZUMAB; TRAFICET; UNCLASSIFIED DRUG; VEDOLIZUMAB;

CROHN DISEASE; DRUG EFFECT; ENTERITIS; HUMAN; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; ANIMAL; INTESTINE; LEUKOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; LEUKOCYTES;

EID: 84855587054     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/808157     Document Type: Review

References (165)

1. Xavier R. J., Podolsky D. K., Unravelling the pathogenesis of inflammatory bowel disease Nature 2007 448 7152 427 434 (Pubitemid 47123518)
2. Naito Y., Takagi T., Yoshikawa T., Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease Journal of Gastroenterology 2007 42 10 787 798 (Pubitemid 47617456)
3. Strober W., Fuss I. J., Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 2011 140 6 1756 1767
4. Melgar S., Shanahan F., Inflammatory bowel disease-from mechanisms to treatment strategies Autoimmunity 2010 43 7 463 477
5. Cho J. H., Brant S. R., Recent insights into the genetics of inflammatory bowel disease Gastroenterology 2011 140 6 1704 1712
6. Targan S. R., Current limitations of IBD treatment: where do we go from here? Annals of the New York Academy of Sciences 2006 1072 1 8 (Pubitemid 44448438)
7. Rutgeerts P., Vermeire S., Van Assche G., Biological therapies for inflammatory bowel diseases Gastroenterology 2009 136 4 1182 1197
8. Waldner M. J., Neurath M. F., Novel cytokine-targeted therapies and intestinal inflammation Current Opinion in Pharmacology 2009 9 6 702 707
9. Gowans J. L., Knight E. J., The route of re-circulation of lymphocytes in the rat Proceedings of the Royal Society of London Series B 1964 159 257 282
10. Bennink R. J., Peeters M., Rutgeerts P., Mortelmans L., Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy Journal of Nuclear Medicine 2004 45 10 1698 1704 (Pubitemid 47618478)
11. Parish C. R., Fluorescent dyes for lymphocyte migration and proliferation studies Immunology and Cell Biology 1999 77 6 499 508
12. Witt C. M., Robbins K., Tracking thymocyte migration in situ Seminars in Immunology 2005 17 6 421 430 (Pubitemid 41654694)
13. Miller M. J., Wei S. H., Cahalan M. D., Parker I., Autonomous T-cell trafficking examined in vivo with intravital two-photon microscopy Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2604 2609 (Pubitemid 36297545)
14. Mankoff D. A., A definition of molecular imaging Journal of Nuclear Medicine 2007 48 6 18 21
15. Herschman H. R., Micro-PET imaging and small animal models of disease Current Opinion in Immunology 2003 15 4 378 384 (Pubitemid 36930072)
16. Nuyts J., Vunckx K., Defrise M., Vanhove C., Small animal imaging with multi-pinhole SPECT Methods 2009 48 2 83 91
17. Bennink R. J., Hamann J., De Bruin K., Ten Kate F. J. W., Van Deventer S. J. H., Te Velde A. A., Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis Journal of Nuclear Medicine 2005 46 3 526 531 (Pubitemid 43093166)
18. Kircher M. F., Allport J. R., Graves E. E., Love V., Josephson L., Lichtman A. H., Weissleder R., In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors Cancer Research 2003 63 20 6838 6846 (Pubitemid 37322966)
19. Millington O. R., Zinselmeyer B. H., Brewer J. M., Garside P., Rush C. M., Lymphocyte tracking and interactions in secondary lymphoid organs Inflammation Research 2007 56 10 391 401 (Pubitemid 350160418)
20. Troy T., Jekic-McMullen D., Sambucetti L., Rice B., Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models Molecular Imaging 2004 3 1 9 23
21. Murphy C. T., Moloney G., Hall L. J., Quinlan A., Faivre E., Casey P., Shanahan F., Melgar S., Nally K., Use of bioluminescence imaging to track neutrophil migration and its inhibition in experimental colitis Clinical and Experimental Immunology 2010 162 1 188 196
22. Murphy C. T., Moloney G., MacSharry J., Haynes A., Faivre E., Quinlan A., McLean P. G., Lee K., O'Mahony L., Shanahan F., Melgar S., Nally K., Technical Advance: function and efficacy of an 4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis Journal of Leukocyte Biology 2010 88 6 1271 1278
23. Sadikot R. T., Blackwell T. S., Bioluminescence imaging Proceedings of the American Thoracic Society 2005 2 6 537 540 (Pubitemid 43128026)
24. Sheikh A. Y., Lin S. A., Cao F., Cao Y., Van Der Bogt K. E. A., Chu P., Chang C. P., Contag C. H., Robbins R. C., Wu J. C., Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium Stem Cells 2007 25 10 2677 2684 (Pubitemid 47582761)
25. Costa G. L., Sandora M. R., Nakajima N., Nguyen E. V., Taylor-Edwards C., Slavin A. J., Contag C. H., Fathman C. G., Benson J. M., Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T-cell delivery of the IL-12 p40 subunit Journal of Immunology 2001 167 4 2379 2387 (Pubitemid 32747553)
26. Ley K., Laudanna C., Cybulsky M. I., Nourshargh S., Getting to the site of inflammation: the leukocyte adhesion cascade updated Nature Reviews Immunology 2007 7 9 678 689 (Pubitemid 47327397)
27. Ley K., Kansas G. S., Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation Nature Reviews Immunology 2004 4 5 325 335 (Pubitemid 38649275)
28. Sperandio M., Selectins and glycosyltransferases in leukocyte rolling in vivo FEBS Journal 2006 273 19 4377 4389 (Pubitemid 44401589)
29. Rossi B., Constantin G., Anti-selectin therapy for the treatment of inflammatory diseases Inflammation and Allergy Drug Targets 2008 7 2 85 93
30. Jalkanen S., Lymphocyte traffic to mucosa-associated lymphatic tissues Immunologic Research 1991 10 3-4 268 270
31. Pierce N. F., Cray W. C., Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats Journal of Immunology 1982 128 3 1311 1315 (Pubitemid 12188457)
32. Xu B., Wagner N., Pham L. N., Magno V., Shan Z., Butcher E. C., Michie S. A., Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, 4 1 integrin/VCAM-1, and LFA-1 adhesion pathways Journal of Experimental Medicine 2003 197 10 1255 1267 (Pubitemid 36617772)
33. Butcher E. C., Williams M., Youngman K., Rott L., Briskin M., Lymphocyte trafficking and regional immunity Advances in Immunology 1999 72 209 253 (Pubitemid 30224828)
34. Kerfoot S. M., Kubes P., Overlapping roles of P-selectin and 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis Journal of Immunology 2002 169 2 1000 1006 (Pubitemid 34753459)
35. Wagner N., Lohler J., Kunkel E. J., Ley K., Leung E., Krissansen G., Rajewsky K., Muller W., Critical role for 7 integrins in formation of the gut-associated lymphoid tissue Nature 1996 382 6589 366 370 (Pubitemid 26260466)
36. Chesnutt B. C., Smith D. F., Raffler N. A., Smith M. L., White E. J., Ley K., Induction of LFA-1-dependent neutrophil rolling on ICAM-1 by engagement of E-selectin Microcirculation 2006 13 2 99 109 (Pubitemid 43216123)
37. Mora J. R., Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids Inflammatory Bowel Diseases 2008 14 2 275 289 (Pubitemid 351288051)
38. Koboziev I., Karlsson F., Grisham M. B., Gut-associated lymphoid tissue, T-cell trafficking, and chronic intestinal inflammation Annals of the New York Academy of Sciences 2010 1207 E86 93
39. Strober W., Fuss I., Mannon P., The fundamental basis of inflammatory bowel disease Journal of Clinical Investigation 2007 117 3 514 521 (Pubitemid 46348505)
40. Kawachi S., Jennings S., Panes J., Cockrell A., Laroux F. S., Gray L., Perry M., Van Der Heyde H., Balish E., Granger D. N., Specian R. A., Grisham M. B., Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice American Journal of Physiology 2000 278 5 G734 G743
41. Rivera-Nieves J., Olson T., Bamias G., Bruce A., Solga M., Knight R. F., Hoang S., Cominelli F., Ley K., L-selectin, 4 1, and 4 7 integrins participate in CD4+ T-cell recruitment to chronically inflamed small intestine Journal of Immunology 2005 174 4 2343 2352
42. Souza H. S., Elia C. C. S., Spencer J., MacDonald T. T., Expression of lymphocyte-endothelial receptor-ligand pairs, 4 7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease Gut 1999 45 6 856 863
43. Arihiro S., Ohtani H., Suzuki M., Murata M., Ejima C., Oki M., Kinouchi Y., Fukushima K., Sasaki I., Nakamura S., Matsumoto T., Torii A., Toda G., Nagura H., Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease Pathology International 2002 52 5-6 367 374 (Pubitemid 34748219)
44. Briskin M., Winsor-Hines D., Shyjan A., Cochran N., Bloom S., Wilson J., McEvoy L. M., Butcher E. C., Kassam N., Mackay C. R., Newman W., Ringler D. J., Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue American Journal of Pathology 1997 151 1 97 110 (Pubitemid 27283962)
45. Abdelbaqi M., Chidlow J. H., Matthews K. M., Pavlick K. P., Barlow S. C., Linscott A. J., Grisham M. B., Fowler M. R., Kevil C. G., Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins Laboratory Investigation 2006 86 4 380 390
46. Pavlick K. P., Ostanin D. V., Furr K. L., Laroux F. S., Brown C. M., Gray L., Kevil C. G., Grisham M. B., Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis International Immunology 2006 18 2 389 398 (Pubitemid 43160151)
47. Rivera-Nieves J., Gorfu G., Ley K., Leukocyte adhesion molecules in animal models of inflammatory bowel disease Inflammatory Bowel Diseases 2008 14 12 1715 1735
48. Simmons D. L., Anti-adhesion therapies Current Opinion in Pharmacology 2005 5 4 398 404 (Pubitemid 40932043)
49. Goto A., Arimura Y., Shinomura Y., Imai K., Hinoda Y., Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis Inflammatory Bowel Diseases 2006 12 8 758 765 (Pubitemid 44253761)
50. Sans M., Panes J., Ardite E., Elizalde J. I., Arce Y., Elena M., Palacin A., Fernandez-Checa J. C., Anderson D. C., Lobb R., Pique J. M., VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis Gastroenterology 1999 116 4 874 883 (Pubitemid 29153535)
51. MacDonald J. K., McDonald J. W., Natalizumab for induction of remission in Crohn's disease Cochrane Database of Systematic Reviews 2007 1, article CD006097
52. Targan S. R., Feagan B. G., Fedorak R. N., Lashner B. A., Panaccione R., Present D. H., Spehlmann M. E., Rutgeerts P. J., Tulassay Z., Volfova M., Wolf D. C., Hernandez C., Bornstein J., Sandborn W. J., Natalizumab for the treatment of active Crohn's Disease: results of the ENCORE Trial Gastroenterology 2007 132 5 1672 1683 (Pubitemid 46695722)
53. Gordon F. H., Hamilton M. I., Donoghue S., Greenlees C., Palmer T., Rowley-Jones D., Dhillon A. P., Amlot P. L., Pounder R. E., A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin Alimentary Pharmacology and Therapeutics 2002 16 4 699 705 (Pubitemid 34407517)
54. Farkas S., Hornung M., Sattler C., Edtinger K., Steinbauer M., Anthuber M., Schlitt H. J., Herfarth H., Geissler E. K., Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis International Journal of Colorectal Disease 2006 21 1 71 78 (Pubitemid 41829768)
55. Kato S., Hokari R., Matsuzaki K., Iwai A., Kawaguchi A., Nagao S., Miyahara T., Itoh K., Ishii H., Miura S., Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1 Journal of Pharmacology and Experimental Therapeutics 2000 295 1 183 189
56. Takazoe M., Watanabe M., Kawaguchi T., S1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in patients with active Crohn's diseasea Randomized, Double-Blind, Placebo-Controlled Trial Gastroenterology 2009 136 A-181
57. Picarella D., Hurlbut P., Rottman J., Shi X., Butcher E., Ringler D. J., Monoclonal antibodies specific for 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid Mice reconstituted with CD45RBhigh CD4+ T cells Journal of Immunology 1997 158 5 2099 2106 (Pubitemid 127469991)
58. Feagan B. G., Greenberg G. R., Wild G., Fedorak R. N., Paré P., McDonald J. W. D., Dubé R., Cohen A., Steinhart A. H., Landau S., Aguzzi R. A., Fox I. H., Vandervoort M. K., Treatment of ulcerative colitis with a humanized antibody to the 4 7 integrin The New England Journal of Medicine 2005 352 24 2499 2507 (Pubitemid 41007865)
59. Behm B. W., Bickston S. J., Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis Cochrane Database of Systematic Reviews 2009 1, article CD007571
60. Feagan B. G., Greenberg G. R., Wild G., Fedorak R. N., Paré P., McDonald J. W.D., Cohen A., Bitton A., Baker J., Dubé R., Landau S. B., Vandervoort M. K., Parikh A., Treatment of active Crohn's disease With MLN0002, a humanized antibody to the 4 7 integrin Clinical Gastroenterology and Hepatology 2008 6 12 1370 1377
61. Matsuzaki K., Tsuzuki Y., Matsunaga H., Inoue T., Miyazaki J., Hokari R., Okada Y., Kawaguchi A., Nagao S., Itoh K., Matsumoto S., Miura S., In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1 Clinical and Experimental Immunology 2005 140 1 22 31 (Pubitemid 40461069)
62. Podolsky D. K., Lobb R., King N., Benjamin C. D., Pepinsky B., Sehgal P., DeBeaumont M., Attenuation of colitis in the cotton-top tamarin by anti- 4 integrin monoclonal antibody Journal of Clinical Investigation 1993 92 1 372 380 (Pubitemid 23209018)
63. Taniguchi T., Tsukada H., Nakamura H., Kodama M., Fukuda K., Saito T., Miyasaka M., Seino Y., Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats Journal of Gastroenterology and Hepatology 1998 13 9 945 949 (Pubitemid 28448968)
64. Bennett C. F., Kornbrust D., Henry S., Stecker K., Howard R., Cooper S., Dutson S., Hall W., Jacoby H. I., An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice Journal of Pharmacology and Experimental Therapeutics 1997 280 2 988 1000 (Pubitemid 27171365)
65. Van Deventer S. J., Wedel M. K., Baker B. F., Xia S., Chuang E., Miner P. B. Jr., A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis Alimentary Pharmacology and Therapeutics 2006 23 10 1415 1425
66. Van Deventer S. J. H., Tami J. A., Wedel M. K., A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis Gut 2004 53 11 1646 1651 (Pubitemid 39434109)
67. Burns R. C., Rivera-Nieves J., Moskaluk C. A., Matsumoto S., Cominelli F., Ley K., Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice Gastroenterology 2001 121 6 1428 1436 (Pubitemid 33140460)
68. Rivera-Nieves J., Ho J., Bamias G., Ivashkina N., Ley K., Oppermann M., Cominelli F., Antibody Blockade of CCL25/CCR9 Ameliorates Early but not Late Chronic Murine Ileitis Gastroenterology 2006 131 5 1518 1529 (Pubitemid 44708936)
69. Walters M. J., Wang Y., Lai N., Baumgart T., Zhao B. N., Dairaghi D. J., Bekker P., Ertl L. S., Penfold M. E. T., Jaen J. C., Keshav S., Wendt E., Pennell A., Ungashe S., Wei Z., Wright J. J. K., Schall T. J., Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease Journal of Pharmacology and Experimental Therapeutics 2010 335 1 61 69
70. Eksteen B., Adams D. H., GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease IDrugs 2010 13 7 472 481
71. Hyun J. G., Lee G., Brown J. B., Grimm G. R., Tang Y., Mittal N., Dirisina R., Zhang Z., Fryer J. P., Weinstock J. V., Luster A. D., Barrett T. A., Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice Inflammatory Bowel Diseases 2005 11 9 799 805 (Pubitemid 41368267)
72. Singh U. P., Singh S., Taub D. D., Lillard J. W., Inhibition of IFN- -inducible protein-10 abrogates colitis in IL-10-/- mice Journal of Immunology 2003 171 3 1401 1406 (Pubitemid 36900073)
73. Sasaki S., Yoneyama H., Suzuki K., Suriki H., Aiba T., Watanabe S., Kawauchi Y., Kawachi H., Shimizu F., Matsushima K., Asakura H., Narumi S., Blockade of CXCL 10 protects mice from acute colitis and enhances crypt cell survival European Journal of Immunology 2002 32 11 3197 3205 (Pubitemid 35414877)
74. Zhong W., Kolls J. K., Chen H., McAllister F., Oliver P. D., Zhang Z., Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease Frontiers in Bioscience 2008 13 5 1654 1664 (Pubitemid 351599723)
75. Frster R., Schubel A., Breitfeld D., Kremmer E., Renner-Mller I., Wolf E., Lipp M., CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 1999 99 1 23 33 (Pubitemid 29468627)
76. Bromley S. K., Thomas S. Y., Luster A. D., Chemokine receptor CCR7 guides T-cell exit from peripheral tissues and entry into afferent lymphatics Nature Immunology 2005 6 9 895 901 (Pubitemid 43090444)
77. Viola A., Luster A. D., Chemokines and their receptors: drug targets in immunity and inflammation Annual Review of Pharmacology and Toxicology 2008 48 171 197 (Pubitemid 351756361)
78. Banks C., Bateman A., Payne R., Johnson P., Sheron N., Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease Journal of Pathology 2003 199 1 28 35 (Pubitemid 36054726)
79. Puleston J., Cooper M., Murch S., Bid K., Makh S., Ashwood P., Bingham A. H., Green H., Moss P., Dhillon A., Morris R., Strobel S., Gelinas R., Pounder R. E., Platt A., A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease Alimentary Pharmacology and Therapeutics 2005 21 2 109 120 (Pubitemid 40222964)
80. Kawashima D., Oshitani N., Jinno Y., Watanabe K., Nakamura S., Higuchi K., Arakawa T., Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease Journal of Clinical Pathology 2005 58 10 1057 1063 (Pubitemid 41416055)
81. Mora J. R., Bono M. R., Manjunath N., Weninger W., Cavanagh L. L., Rosemblatt M., Von Andrian U. H., Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells Nature 2003 424 6944 88 93 (Pubitemid 36834847)
82. Stagg A. J., Kamm M. A., Knight S. C., Intestinal dendritic cells increase T-cell expression of 4 7 integrin European Journal of Immunology 2002 32 5 1445 1454 (Pubitemid 34546273)
83. Johansson-Lindbom B., Svensson M., Wurbel M. A., Malissen B., Mrquez G., Agace W., Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant Journal of Experimental Medicine 2003 198 6 963 969 (Pubitemid 37152933)
84. Mora J. R., Cheng G., Picarella D., Briskin M., Buchanan N., Von Andrian U. H., Reciprocal and dynamic control of CD8 T-cell homing by dendritic cells from skin- and gut-associated lymphoid tissues Journal of Experimental Medicine 2005 201 2 303 316 (Pubitemid 40189439)
85. Johansson-Lindbom B., Svensson M., Pabst O., Palmqvist C., Marquez G., Frster R., Agace W. W., Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T-cell homing Journal of Experimental Medicine 2005 202 8 1063 1073 (Pubitemid 41464500)
86. Jaensson E., Uronen-Hansson H., Pabst O., Eksteen B., Tian J., Coombes J. L., Berg P. L., Davidsson T., Powrie F., Johansson-Lindbom B., Agace W. W., Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans Journal of Experimental Medicine 2008 205 9 2139 2149
87. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., Song S. Y., Retinoic acid imprints gut-homing specificity on T cells Immunity 2004 21 4 527 538 (Pubitemid 39370508)
88. Manicassamy S., Pulendran B., Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages Seminars in Immunology 2009 21 1 22 27
89. Svensson M., Johansson-Lindbom B., Zapata F., Jaensson E., Austenaa L. M., Blomhoff R., Agace W. W., Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells Mucosal Immunology 2008 1 1 38 48
90. Stagg A. J., Norin K. E., Midtvedt T., Kamm M. A., Knight S. C., Bjrkstén B., Mesenteric dendritic cells from germ-free mice cause less T-cell stimulation but still induce 4 7 integrin Microbial Ecology in Health and Disease 2007 19 3 171 183 (Pubitemid 47402878)
91. Ng S. C., Kamm M. A., Stagg A. J., Knight S. C., Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation Inflammatory Bowel Diseases 2010 16 10 1787 1807
92. Coombes J. L., Siddiqui K. R. R., Arancibia-Crcamo C. V., Hall J., Sun C. M., Belkaid Y., Powrie F., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF- -and retinoic acid-dependent mechanism Journal of Experimental Medicine 2007 204 8 1757 1764 (Pubitemid 47236314)
93. Kang S. G., Wang C., Matsumoto S., Kim C. H., High and low vitamin A therapies induce distinct foxP3+ T-cell subsets and effectively control intestinal inflammation Gastroenterology 2009 137 4 1391 e6
94. Chi H., Sphingosine-1-phosphate and immune regulation: trafficking and beyond Trends in Pharmacological Sciences 2011 32 1 16 24
95. Meyer zu Heringdorf D., Jakobs K. H., Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism Biochimica et Biophysica Acta 2007 1768 4 923 940 (Pubitemid 46452543)
96. Chae S. S., Proia R. L., Hla T., Constitutive expression of the S1P1 receptor in adult tissues Prostaglandins and Other Lipid Mediators 2004 73 1-2 141 150 (Pubitemid 38446477)
97. Graeler M., Goetzl E. J., Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells FASEB Journal 2002 16 14 1874 1878 (Pubitemid 35462606)
98. Jaillard C., Harrison S., Stankoff B., Aigrot M. S., Calver A. R., Duddy G., Walsh F. S., Pangalos M. N., Arimura N., Kaibuchi K., Zalc B., Lubetzki C., Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival Journal of Neuroscience 2005 25 6 1459 1469 (Pubitemid 40250722)
99. Matloubian M., Lo C. G., Cinamon G., Lesneski M. J., Xu Y., Brinkmann V., Allende M. L., Proia R. L., Cyster J. G., Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 2004 427 6972 355 360 (Pubitemid 38133663)
100. Shiow L. R., Rosen D. B., Brdikov N., Xu Y., An J., Lanier L. L., Cyster J. G., Matloubian M., CD69 acts downstream of interferon- / to inhibit S1P 1 and lymphocyte egress from lymphoid organs Nature 2006 440 7083 540 544
101. Pham T. H. M., Okada T., Matloubian M., Lo C. G., Cyster J. G., S1P1 receptor signaling overrides retention mediated by G i-coupled receptors to promote T-cell egress Immunity 2008 28 1 122 133
102. Rathinasamy A., Czeloth N., Pabst O., Frster R., Bernhardt G., The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration Journal of Immunology 2010 185 7 4072 4081
103. Allende M. L., Bektas M., Lee B. G., Bonifacino E., Kang J., Tuymetova G., Chen W., Saba J. D., Proia R. L., Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking Journal of Biological Chemistry 2011 286 9 7348 7358
104. Walzer T., Chiossone L., Chaix J., Calver A., Carozzo C., Garrigue-Antar L., Jacques Y., Baratin M., Tomasello E., Vivier E., Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor Nature Immunology 2007 8 12 1337 1344 (Pubitemid 350131171)
105. Spiege S., Milstien S., The outs and the ins of sphingosine-1-phosphate in immunity Nature Reviews Immunology 2011 11 403 415
106. Ammit A. J., Hastie A. T., Edsall L. C., Hoffman R. K., Amrani Y., Krymskaya V. P., Kane S. A., Peters S. P., Penn R. B., Spiegel S., Panettieri R. A., Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma The FASEB Journal 2001 15 7 1212 1214
107. Kitano M., Hla T., Sekiguchi M., Kawahito Y., Yoshimura R., Miyazawa K., Iwasaki T., Sano H., Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression Arthritis and Rheumatism 2006 54 3 742 753
108. Brinkmann V., Billich A., Baumruker T., Heining P., Schmouder R., Francis G., Aradhye S., Burtin P., Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nature Reviews Drug Discovery 2010 9 11 883 897
109. Chiba K., A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720) Yakugaku Zasshi 2009 129 6 655 665
110. Lan Y. Y., De Creus A., Colvin B. L., Abe M., Brinkmann V., Coates P. T. H., Thomson A. W., The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo American Journal of Transplantation 2005 5 11 2649 2659
111. Budde K., Schmouder R. L., Nashan B., Brunkhorst R., Lcker P. W., Mayer T., Brookman L., Nedelman J., Skerjanec A., Bhler T., Neumayer H. H., Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients American Journal of Transplantation 2003 3 7 846 854 (Pubitemid 36827906)
112. Budde K., Schmouder R. L., Brunkhorst R., Nashan B., Lcker P. W., Mayer T., Choudhury S., Skerjanec A., Kraus G., Neumayer H. H., First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients Journal of the American Society of Nephrology 2002 13 4 1073 1083 (Pubitemid 34274106)
113. Kahan B. D., Karlix J. L., Ferguson R. M., Leichtman A. B., Mulgaonkar S., Gonwa T. A., Skerjanec A., Schmouder R. L., Chodoff L., Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study Transplantation 2003 76 7 1079 1084 (Pubitemid 37280837)
114. Tedesco-Silva H., Mourad G., Kahan B. D., Boira J. G., Weimar W., Mulgaonkar S., Nashan B., Madsen S., Charpentier B., Pellet P., Vanrenterghem Y., FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation Transplantation 2005 79 11 1553 1560 (Pubitemid 40847587)
115. Daniel C., Sartory N., Zahn N., Geisslinger G., Radeke H. H., Stein J. M., FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells Journal of Immunology 2007 178 4 2458 2468 (Pubitemid 46233446)
116. Deguchi Y., Andoh A., Yagi Y., Bamba S., Inatomi O., Tsujikawa T., Fujiyama Y., The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice Oncology Reports 2006 16 4 699 703
117. Daniel C., Sartory N. A., Zahn N., Schmidt R., Geisslinger G., Radeke H. H., Stein J. M., FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions Molecular Immunology 2007 44 13 3305 3316 (Pubitemid 46678202)
118. Fujii R., Kanai T., Nemoto Y., Makita S., Oshima S., Okamoto R., Tsuchiya K., Totsuka T., Watanabe M., FTY720 suppresses CD4+CD44highCD62L- effector memory T-cell-mediated colitis American Journal of Physiology 2006 291 2 G267 G274
119. Mizushima T., Ito T., Kishi D., Kai Y., Tamagawa H., Nezu R., Kiyono H., Matsuda H., Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis Inflammatory Bowel Diseases 2004 10 3 182 192 (Pubitemid 38618245)
120. Awad A. S., Ye H., Huang L., Foss F. W., Macdonald T. L., Lynch K. R., Okusa M. D., Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney American Journal of Physiology 2006 290 6 F1516 F1524
121. Bolick D. T., Srinivasan S., Kim K. W., Hatley M. E., Clemens J. J., Whetzel A., Ferger N., Macdonald T. L., Davis M. D., Tsao P. S., Lynch K. R., Hedrick C. C., Sphingosine-1-phosphate prevents tumor necrosis factor- -mediated monocyte adhesion to aortic endothelium in mice Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 976 981 (Pubitemid 40627842)
122. Song J., Matsuda C., Kai Y., Nishida T., Nakajima K., Mizushima T., Kinoshita M., Yasue T., Sawa Y., Ito T., A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice Journal of Pharmacology and Experimental Therapeutics 2008 324 1 276 283 (Pubitemid 350294170)
123. Miller D. H., Khan O. A., Sheremata W. A., Blumhardt L. D., Rice G. P. A., Libonati M. A., Willmer-Hulme A. J., Dalton C. M., Miszkiel K. A., O'Connor P. W., A controlled trial of natalizumab for relapsing multiple sclerosis The New England Journal of Medicine 2003 348 1 15 23 (Pubitemid 36026342)
124. Rudick R. A., Stuart W. H., Calabresi P. A., Confavreux C., Galetta S. L., Radue E. W., Lublin F. D., Weinstock-Guttman B., Wynn D. R., Lynn F., Panzara M. A., Sandrock A. W., Natalizumab plus interferon beta-1a for relapsing multiple sclerosis The New England Journal of Medicine 2006 354 9 911 923
125. Stuve O., Gold R., Chan A., Mix E., Zettl U., Kieseier B. C., 4-Integrin antagonism with natalizumab: effects and adverse effects Journal of Neurology 2008 255 supplement 6 58 65
126. Hesterberg P. E., Winsor-Hines D., Briskin M. J., Soler-Ferran D., Merrill C., Mackay C. R., Newman W., Ringler D. J., Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin 4 7 Gastroenterology 1996 111 5 1373 1380 (Pubitemid 26362264)
127. Barish C. F., Alicaforsen therapy in inflammatory bowel disease Expert Opinion on Biological Therapy 2005 5 10 1387 1391 (Pubitemid 41503049)
128. Yacyshyn B., Chey W. Y., Wedel M. K., Yu R. Z., Paul D., Chuang E., A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease Clinical Gastroenterology and Hepatology 2007 5 2 215 220 (Pubitemid 46216935)
129. Yacyshyn B. R., Chey W. Y., Goff J., Salzberg B., Baerg R., Buchman A. L., Tami J., Yu R., Gibiansky E., Shanahan W. R., Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease Gut 2002 51 1 30 36 (Pubitemid 34717740)
130. Schreiber S., Nikolaus S., Malchow H., Kruis W., Lochs H., Raedler A., Hahn E. G., Krummenerl T., Steinmann G., Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease Gastroenterology 2001 120 6 1339 1346 (Pubitemid 32322307)
131. Miner P. Jr., Wedel M., Bane B., Bradley J., An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis Alimentary Pharmacology and Therapeutics 2004 19 3 281 286 (Pubitemid 38253502)
132. Bommakanti S., Patil A., Eshoa C., Chitambar C. R., Case reports: efalizumab-associated lymphoproliferative disease Journal of Drugs in Dermatology 2007 6 6 646 648
133. Okigami H., Takeshita K., Tajimi M., Komura H., Albers M., Lehmann T. E., Rlle T., Bacon K. B., Inhibition of eosinophilia in vivo by a small molecule
134. Cortijo J., Sanz M. J., Iranzo A., Montesinos J. L., Abu Nabah Y. N., Alfn J., Gmez L. A., Merlos M., Morcillo E. J., A small molecule, orally active, 4 1/ 4 7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats British Journal of Pharmacology 2006 147 6 661 670
135. Johansson-Lindbom B., Agace W. W., Generation of gut-homing T cells and their localization to the small intestinal mucosa Immunological Reviews 2007 215 1 226 242 (Pubitemid 46212243)
136. Koenecke C., Frster R., CCR9 and inflammatory bowel disease Expert Opinion on Therapeutic Targets 2009 13 3 297 306
137. Wermers J. D., McNamee E. N., Wurbel M. A., Jedlicka P., Rivera-Nieves J., The Chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice Gastroenterology 2011 140 5 1526 1535.e3
138. Wurbel M. A., McIntire M. G., Dwyer P., Fiebiger E., CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis PLoS ONE 2011 6 1, article e16442
139. Kunkel E. J., Campbell J. J., Haraldsen G., Pan J., Boisvert J., Roberts A. I., Ebert E. C., Vierra M. A., Goodman S. B., Genovese M. C., Wardlaw A. J., Greenberg H. B., Parker C. M., Butcher E. C., Andrew D. P., Agace W. W., Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity Journal of Experimental Medicine 2000 192 5 761 767
140. Piali L., Weber C., LaRosa G., Mackay C. R., Springer T. A., Clark-Lewis I., Moser B., The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig European Journal of Immunology 1998 28 3 961 972 (Pubitemid 28116209)
141. Bonecchi R., Bianchi G., Bordignon P. P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P. A., Mantovani A., Sinigaglia F., Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s Journal of Experimental Medicine 1998 187 1 129 134 (Pubitemid 28044828)
142. Singh U. P., Venkataraman C., Singh R., Lillard J. W. Jr., CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication Endocrine, Metabolic and Immune Disorders Drug Targets 2007 7 2 111 123 (Pubitemid 46969859)
143. Scarpini E., Galimberti D., Baron P., Clerici R., Ronzoni M., Conti G., Scarlato G., IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease Journal of the Neurological Sciences 2002 195 1 41 46 (Pubitemid 34175097)
144. Hanaoka R., Kasama T., Muramatsu M., Yajima N., Shiozawa F., Miwa Y., Negishi M., Ide H., Miyaoka H., Uchida H., Adachi M., A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis Arthritis Research and Therapy 2003 5 2 R74 81
145. Aggarwal A., Agarwal S., Misra R., Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA) Clinical and Experimental Immunology 2007 148 3 515 519 (Pubitemid 46701039)
146. Loetscher P., Pellegrino A., Gong J. H., Mattioli I., Loetscher M., Bardi G., Baggiolini M., Clark-Lewis I., The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3 Journal of Biological Chemistry 2001 276 5 2986 2991
147. Byrne F. R., Winters A., Brankow D., Hu S., Juan T., Steavenson S., Doellgast G., Kuchimanchi K., Brown H., Anderson S., Smelt S., Sullivan T., Alcorn D., Tocker J., Dean C., Macmaster J., Kirchner J., Buys J., Manoukian R., Jiao E., Zou X., Campanella G., Siu G., An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation Autoimmunity 2009 42 3 171 182
148. Palmen M. J. H. J., Dijkstra C. D., Van Der Ende M. B., Pena A. S., Van Rees E. P., Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats Clinical and Experimental Immunology 1995 101 2 351 356
149. Kobayashi Y., Neutrophil infiltration and chemokines Critical Reviews in Immunology 2006 26 4 307 315 (Pubitemid 44423549)
150. Melgar S., Drmotova M., Rehnstrm E., Jansson L., Michalsson E., Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis Cytokine 2006 35 5-6 275 283 (Pubitemid 44827746)
151. Hanai H., Takeuchi K., Iida T., Kashiwagi N., Saniabadi A. R., Matsushita I., Sato Y., Kasuga N., Nakamura T., Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis Digestive Diseases and Sciences 2004 49 9 1438 1443 (Pubitemid 39273619)
152. Podolin P. L., Bolognese B. J., Foley J. J., Schmidt D. B., Buckley P. T., Widdowson K. L., Jin Q., White J. R., Lee J. M., Goodman R. B., Hagen T. R., Kajikawa O., Marshall L. A., Hay D. W. P., Sarau H. M., A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit Journal of Immunology 2002 169 11 6435 6444 (Pubitemid 36903493)
153. Schuh J. M., Blease K., Hogaboam C. M., CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice Journal of Immunology 2002 168 3 1447 1456 (Pubitemid 34094518)
154. Buanne P., Di Carlo E., Caputi L., Brandolini L., Mosca M., Cattani F., Pellegrini L., Biordi L., Coletti G., Sorrentino C., Fedele G., Colotta F., Melillo G., Bertini R., Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice Journal of Leukocyte Biology 2007 82 5 1239 1246 (Pubitemid 350133522)
155. Bento A. F., Leite D. F. P., Claudino R. F., Hara D. B., Leal P. C., Calixto J. B., The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice Journal of Leukocyte Biology 2008 84 4 1213 1221
156. Schall T. J., Proudfoot A. E., Overcoming hurdles in developing successful drugs targeting chemokine receptors Nature Reviews Immunology 2011 11 5 355 363
157. Keshav S., Johnson D., Bekker P., Schall T. J., PROTECT-1 study demonstrated efficacy of the intestine-specific chemokine receptor antagonist CCX282-B (Traficet-EN) in treatment of patients with moderate-to-severe Crohn's disease Gastroenterology 2009 136 A-65
158. Mattes J., Collison A., Plank M., Phipps S., Foster P. S., Antagonism of microRNA-126 suppresses the effector function of T H2 cells and the development of allergic airways disease Proceedings of the National Academy of Sciences of the United States of America 2009 106 44 18704 18709
159. Surez Y., Fernndez-Hernando C., Pober J. S., Sessa W. C., Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells Circulation Research 2007 100 8 1164 1173 (Pubitemid 46684129)
160. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G., MicroRNAs modulate the angiogenic properties of HUVECs Blood 2006 108 9 3068 3071
161. Harris T. A., Yamakuchi M., Ferlito M., Mendell J. T., Lowenstein C. J., MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1516 1521 (Pubitemid 351346546)
162. Surez Y., Wang C., Manes T. D., Pober J. S., Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation Journal of Immunology 2010 184 1 21 25
163. Nguyen H. T. T., Dalmasso G., Yan Y., Laroui H., Dahan S., Mayer L., Sitaraman S. V., Merlin D., MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation Journal of Biological Chemistry 2010 285 2 1479 1489
164. Glauben R., Siegmund B., Inhibition of histone deacetylases in inflammatory bowel diseases Molecular Medicine 2011 17 5-6 426 433
165. Nicodeme E., Jeffrey K. L., Schaefer U., Beinke S., Dewell S., Chung C. W., Chandwani R., Marazzi I., Wilson P., Coste H., White J., Kirilovsky J., Rice C. M., Lora J. M., Prinjha R. K., Lee K., Tarakhovsky A., Suppression of inflammation by a synthetic histone mimic Nature 2010 468 7327 1119 1123